# reload+after+2024-01-23 06:40:43.185654
address1§Phoenix Court
address2§Unit 3 Lotherton Way
city§Garforth
zip§LS25 2GY
country§United Kingdom
phone§44 33 0430 3052
fax§44 19 0438 0517
website§https://www.tissueregenix.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. It operates in three segments: dCELL, BioRinse, and GBM-V. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. It also offers DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, a decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. In addition, it provides OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Further, the company offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom.
fullTimeEmployees§85
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Daniel Ray Lee', 'age': 62, 'title': 'CEO & Director', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 456617, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David Claiborne Cocke', 'age': 57, 'title': 'CFO & Executive Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 270355, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Christine  Rowley', 'title': 'Technical & Operations Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kirsten Mary Lund', 'title': 'EMEA Business Director & Company Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.422
priceToSalesTrailing12Months§1.3725314
currency§GBp
forwardEps§0.73
exchange§LSE
quoteType§EQUITY
shortName§TISSUE REGENIX GROUP PLC ORD 0.
longName§Tissue Regenix Group plc
firstTradeDateEpochUtc§1166688000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§449aac2b-9980-3e6d-aece-3d9d82b93062
recommendationMean§2.0
recommendationKey§buy
quickRatio§1.724
grossMargins§0.47726002
ebitdaMargins§-0.00711
trailingPegRatio§None
